Compare AbCellera Biologics Inc (ABCL) vs EPR Properties (EPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs EPR Properties — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while EPR Properties trades at $60 (market cap $4.58B). The key difference: EPR Properties is the larger of the two by market cap, and EPR Properties pays a 6.22% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | EPR | |
|---|---|---|
Market Cap | $2.99B | $4.58B |
Sector | Health | Real Estate |
52-Week High | $9.76 | $64.32 |
52-Week Low | $2.78 | $48.71 |
Enterprise Value | $2.58B | $8.09B |
Dividend Yield | — | 6.22% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →
